skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: Base de dados/Biblioteca: WK Lippincott Williams & Wilkins–Connect here FIRST to enable access remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Prospective, randomized, double-blind, Phase 2 dose-ranging study comparing efficacy and safety of imipenem/cilastatin plus relebactam with imipenem/cilastatin alone in patients with complicated urinary tract infections
Prospective, randomized, double-blind, Phase 2 dose-ranging study comparing efficacy and safety of imipenem/cilastatin plus relebactam with imipenem/cilastatin alone in patients with complicated urinary tract infections
Material Type:
Artigo 		Adicionar ao Meu Espaço

Prospective, randomized, double-blind, Phase 2 dose-ranging study comparing efficacy and safety of imipenem/cilastatin plus relebactam with imipenem/cilastatin alone in patients with complicated urinary tract infections

Sims, Matthew ; Mariyanovski, Valeri ; McLeroth, Patrick ; Akers, Wayne ; Lee, Yu-Chieh ; Brown, Michelle L ; Du, Jiejun ; Pedley, Alison ; Kartsonis, Nicholas A ; Paschke, Amanda

Journal of antimicrobial chemotherapy, 2017-09, Vol.72 (9), p.2616-2626 [Periódico revisado por pares]

England

Texto completo disponível

Citações Citado por
2
PIN28 A US Payer Cost-Effectiveness Analysis of Imipenem/Cilastatin/Relebactam Versus Colistin Plus Imipenem/Cilastatin in Patients with Carbapenem-Resistant Bacterial Infections
PIN28 A US Payer Cost-Effectiveness Analysis of Imipenem/Cilastatin/Relebactam Versus Colistin Plus Imipenem/Cilastatin in Patients with Carbapenem-Resistant Bacterial Infections
Material Type:
Artigo 		Adicionar ao Meu Espaço

PIN28 A US Payer Cost-Effectiveness Analysis of Imipenem/Cilastatin/Relebactam Versus Colistin Plus Imipenem/Cilastatin in Patients with Carbapenem-Resistant Bacterial Infections

Naik, J. ; Ralph, L. ; Massello, M. ; Dillon, R. ; Mccann, E. ; Yang, J.

Value in health, 2021-06, Vol.24, p.S110-S110 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
3
1951. Nephrotoxicity Associated With Imipenem/Cilastatin/Relebactam (IMI/REL) vs. Imipenem/Cilastatin Plus Colistin (IMI+CST) in Patients With Imipenem-Nonsusceptible (NS) Bacterial Infections
1951. Nephrotoxicity Associated With Imipenem/Cilastatin/Relebactam (IMI/REL) vs. Imipenem/Cilastatin Plus Colistin (IMI+CST) in Patients With Imipenem-Nonsusceptible (NS) Bacterial Infections
Material Type:
Artigo 		Adicionar ao Meu Espaço

1951. Nephrotoxicity Associated With Imipenem/Cilastatin/Relebactam (IMI/REL) vs. Imipenem/Cilastatin Plus Colistin (IMI+CST) in Patients With Imipenem-Nonsusceptible (NS) Bacterial Infections

Brown, Michelle ; Motsch, Johann ; Kaye, Keith ; File, Thomas ; Boucher, Helen W ; Vendetti, Neika ; Aggrey, Angela ; Joeng, Hee-Koung ; Tipping, Robert ; Du, Jiejun ; Depestel, Daryl D ; Butterton, Joan ; Kartsonis, Nicholas A ; Paschke, Amanda

Open forum infectious diseases, 2018-11, Vol.5 (suppl_1), p.S563-S563 [Periódico revisado por pares]

US: Oxford University Press

Texto completo disponível

Citações Citado por
4
1339. Results for the Supplemental Microbiological Modified Intent-to-Treat (SmMITT) Population of the RESTORE-IMI 1 Trial of Imipenem/Cilastatin/Relebactam (IMI/REL) vs. Imipenem/Cilastatin Plus Colistin (IMI+CST) in Patients with Imipenem-Nonsusceptible (NS) Bacterial Infections
1339. Results for the Supplemental Microbiological Modified Intent-to-Treat (SmMITT) Population of the RESTORE-IMI 1 Trial of Imipenem/Cilastatin/Relebactam (IMI/REL) vs. Imipenem/Cilastatin Plus Colistin (IMI+CST) in Patients with Imipenem-Nonsusceptible (NS) Bacterial Infections
Material Type:
Artigo 		Adicionar ao Meu Espaço

1339. Results for the Supplemental Microbiological Modified Intent-to-Treat (SmMITT) Population of the RESTORE-IMI 1 Trial of Imipenem/Cilastatin/Relebactam (IMI/REL) vs. Imipenem/Cilastatin Plus Colistin (IMI+CST) in Patients with Imipenem-Nonsusceptible (NS) Bacterial Infections

Kaye, Keith ; File, Thomas ; Boucher, Helen W ; Brown, Michelle ; Aggrey, Angela ; Khan, Ireen ; Joeng, Hee-Koung ; Tipping, Robert ; Du, Jiejun ; Young, Katherine ; Butterton, Joan ; Kartsonis, Nicholas A ; Paschke, Amanda

Open forum infectious diseases, 2018-11, Vol.5 (suppl_1), p.S409-S409 [Periódico revisado por pares]

US: Oxford University Press

Texto completo disponível

Citações Citado por
5
Results of a randomized trial comparing sequential intravenous/oral treatment with ciprofloxacin plus metronidazole to imipenem/cilastatin for intra-abdominal infections
Results of a randomized trial comparing sequential intravenous/oral treatment with ciprofloxacin plus metronidazole to imipenem/cilastatin for intra-abdominal infections
Material Type:
Artigo 		Adicionar ao Meu Espaço

Results of a randomized trial comparing sequential intravenous/oral treatment with ciprofloxacin plus metronidazole to imipenem/cilastatin for intra-abdominal infections

SOLOMKIN, J. S ; REINHART, H. H ; COULTER, H. O ; ECHOLS, R. M ; DELLINGER, E. P ; BOHNEN, J. M ; ROTSTEIN, O. D ; VOGEL, S. B ; SIMMS, H. H ; HILL, C. S ; BJORNSON, H. S ; HAVERSTOCK, D. C

Annals of surgery, 1996-03, Vol.223 (3), p.303-315 [Periódico revisado por pares]

Hagerstown, MD: Lippincott

Texto completo disponível

Citações Citado por
6
Imipenem/cilastatin/relebactam: A new carbapenem β-lactamase inhibitor combination
Imipenem/cilastatin/relebactam: A new carbapenem β-lactamase inhibitor combination
Material Type:
Artigo 		Adicionar ao Meu Espaço

Imipenem/cilastatin/relebactam: A new carbapenem β-lactamase inhibitor combination

Mansour, Hanine ; Ouweini, Ahmad E L ; Chahine, Elias B ; Karaoui, Lamis R

American journal of health-system pharmacy, 2021-03, Vol.78 (8), p.674-683 [Periódico revisado por pares]

US: Oxford University Press

Texto completo disponível

Citações Citado por
7
Cost effectiveness of ciprofloxacin plus metronidazole versus imipenem-cilastatin in the treatment of intra-abdominal infections
Cost effectiveness of ciprofloxacin plus metronidazole versus imipenem-cilastatin in the treatment of intra-abdominal infections
Material Type:
Artigo 		Adicionar ao Meu Espaço

Cost effectiveness of ciprofloxacin plus metronidazole versus imipenem-cilastatin in the treatment of intra-abdominal infections

Walters, D J ; Solomkin, J S ; Paladino, J A

PharmacoEconomics, 1999-11, Vol.16 (5 Pt 2), p.551-561 [Periódico revisado por pares]

New Zealand: Springer Healthcare | Adis

Texto completo disponível

Citações Citado por
8
Impact of renal impairment and human organic anion transporter inhibition on pharmacokinetics, safety and tolerability of relebactam combined with imipenem and cilastatin
Impact of renal impairment and human organic anion transporter inhibition on pharmacokinetics, safety and tolerability of relebactam combined with imipenem and cilastatin
Material Type:
Artigo 		Adicionar ao Meu Espaço

Impact of renal impairment and human organic anion transporter inhibition on pharmacokinetics, safety and tolerability of relebactam combined with imipenem and cilastatin

Bhagunde, Pratik ; Colon‐Gonzalez, Francheska ; Liu, Yang ; Wu, Jin ; Xu, Shiyao Sherrie ; Garrett, Graigory ; Jumes, Patricia ; Lasseter, Kenneth ; Marbury, Thomas ; Rizk, Matthew L. ; Lala, Mallika ; Rhee, Elizabeth G. ; Butterton, Joan R. ; Boundy, Keith

British journal of clinical pharmacology, 2020-05, Vol.86 (5), p.944-957 [Periódico revisado por pares]

England: John Wiley and Sons Inc

Texto completo disponível

Citações Citado por
9
Results of a randomized trial comparing sequential intravenous/oral treatment with ciprofloxacin plus metronidazole to imipenem/cilastatin for intra-abdominal infections. The Intra-Abdominal Infection Study Group
Results of a randomized trial comparing sequential intravenous/oral treatment with ciprofloxacin plus metronidazole to imipenem/cilastatin for intra-abdominal infections. The Intra-Abdominal Infection Study Group
Material Type:
Artigo 		Adicionar ao Meu Espaço

Results of a randomized trial comparing sequential intravenous/oral treatment with ciprofloxacin plus metronidazole to imipenem/cilastatin for intra-abdominal infections. The Intra-Abdominal Infection Study Group

Solomkin, J S ; Reinhart, H H ; Dellinger, E P ; Bohnen, J M ; Rotstein, O D ; Vogel, S B ; Simms, H H ; Hill, C S ; Bjornson, H S ; Haverstock, D C ; Coulter, H O ; Echols, R M

Annals of surgery, 1996-03, Vol.223 (3), p.303-315 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
10
Evaluation of Renal Safety Between Imipenem/Relebactam and Colistin Plus Imipenem in Patients With Imipenem-Nonsusceptible Bacterial Infections in the Randomized, Phase 3 RESTORE-IMI 1 Study
Evaluation of Renal Safety Between Imipenem/Relebactam and Colistin Plus Imipenem in Patients With Imipenem-Nonsusceptible Bacterial Infections in the Randomized, Phase 3 RESTORE-IMI 1 Study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Evaluation of Renal Safety Between Imipenem/Relebactam and Colistin Plus Imipenem in Patients With Imipenem-Nonsusceptible Bacterial Infections in the Randomized, Phase 3 RESTORE-IMI 1 Study

Brown, Michelle L ; Motsch, Johann ; Kaye, Keith S ; File, Thomas M ; Boucher, Helen W ; Vendetti, Neika ; Aggrey, Angela ; Joeng, Hee-Koung ; Tipping, Robert W ; Du, Jiejun ; DePestel, Daryl D ; Butterton, Joan R ; Paschke, Amanda

Open forum infectious diseases, 2020-03, Vol.7 (3), p.ofaa054 [Periódico revisado por pares]

US: Oxford University Press

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (824)

Data de Publicação 

De até
Refinar
  1. Antes de1992  (10)
  2. 1992Até1999  (81)
  3. 2000Até2007  (236)
  4. 2008Até2016  (274)
  5. Após 2016  (245)
  6. Mais opções open sub menu

Idioma 

  1. Japonês  (78)
  2. Alemão  (5)
  3. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.